The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher ...

To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its mRNA flu vaccine. Meanwhile, regulators are moving ...

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.

Solitary reflection is essential to clinical work, but it can also quietly narrow the range of perspectives a therapist ...

The U.S. Food and Drug Administration refused to review Moderna’s application for a new influenza vaccine, a surprise decision that could raise concerns about the agency’s posture toward drug ...

Realfood.gov now features a chatbot tool that’s Elon Musk-affiliated — and rather skeptical of some MAHA initiatives.

A Christian group announces a potentially landmark legal settlement that the ACLU says could establish new federal ...

Over the last few years, Abridge has become one of the leading artificial intelligence companies in health care. It’s got a multi-billion dollar valuation and an ambient scribe used by hundreds of ...

It’s a surprising decision that could raise concerns about the agency’s posture toward drug companies and, of course, the administration’s policies on vaccines overall. Moderna’s rejection is only the ...